PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14724828-3	2003	In 2 variations of the model an antisense oligonucleotide for nuclear factor kappa B (NF-kappa B) p65 was given prophylactically or therapeutically to block chronic inflammation-associated fibrosis.	Oligonucleotides	42-57	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	62-84	
14724828-3	2003	In 2 variations of the model an antisense oligonucleotide for nuclear factor kappa B (NF-kappa B) p65 was given prophylactically or therapeutically to block chronic inflammation-associated fibrosis.	Oligonucleotides	42-57	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	86-96	
14724828-3	2003	In 2 variations of the model an antisense oligonucleotide for nuclear factor kappa B (NF-kappa B) p65 was given prophylactically or therapeutically to block chronic inflammation-associated fibrosis.	Oligonucleotides	42-57	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	98-101	
14724828-8	2003	RESULTS: Colons of TNBS-treated mice contained acute and chronic inflammatory infiltrates, increased collagen, fibrogenic tissue architecture, and increased expression of TNF-alpha, TGF-beta 1, IGF-1, Col1a2, MMP-1, and TIMP-1.	Trinitrobenzenesulfonic Acid	19-23	tumor necrosis factor	Mus musculus	171-180	
14724828-8	2003	RESULTS: Colons of TNBS-treated mice contained acute and chronic inflammatory infiltrates, increased collagen, fibrogenic tissue architecture, and increased expression of TNF-alpha, TGF-beta 1, IGF-1, Col1a2, MMP-1, and TIMP-1.	Trinitrobenzenesulfonic Acid	19-23	transforming growth factor, beta 1	Mus musculus	182-192	
14724828-8	2003	RESULTS: Colons of TNBS-treated mice contained acute and chronic inflammatory infiltrates, increased collagen, fibrogenic tissue architecture, and increased expression of TNF-alpha, TGF-beta 1, IGF-1, Col1a2, MMP-1, and TIMP-1.	Trinitrobenzenesulfonic Acid	19-23	insulin-like growth factor 1	Mus musculus	194-199	
14724828-8	2003	RESULTS: Colons of TNBS-treated mice contained acute and chronic inflammatory infiltrates, increased collagen, fibrogenic tissue architecture, and increased expression of TNF-alpha, TGF-beta 1, IGF-1, Col1a2, MMP-1, and TIMP-1.	Trinitrobenzenesulfonic Acid	19-23	collagen, type I, alpha 2	Mus musculus	201-207	
14724828-8	2003	RESULTS: Colons of TNBS-treated mice contained acute and chronic inflammatory infiltrates, increased collagen, fibrogenic tissue architecture, and increased expression of TNF-alpha, TGF-beta 1, IGF-1, Col1a2, MMP-1, and TIMP-1.	Trinitrobenzenesulfonic Acid	19-23	matrix metallopeptidase 13	Mus musculus	209-214	
14724828-8	2003	RESULTS: Colons of TNBS-treated mice contained acute and chronic inflammatory infiltrates, increased collagen, fibrogenic tissue architecture, and increased expression of TNF-alpha, TGF-beta 1, IGF-1, Col1a2, MMP-1, and TIMP-1.	Trinitrobenzenesulfonic Acid	19-23	tissue inhibitor of metalloproteinase 1	Mus musculus	220-226	
14724828-9	2003	Colonic mesenchymal cells from TNBS-treated mice were also morphologically distinct from those of the control mice, with increased TIMP-1 expression in response to IFN-gamma treatment.	Trinitrobenzenesulfonic Acid	31-35	tissue inhibitor of metalloproteinase 1	Mus musculus	131-137	
14724828-9	2003	Colonic mesenchymal cells from TNBS-treated mice were also morphologically distinct from those of the control mice, with increased TIMP-1 expression in response to IFN-gamma treatment.	Trinitrobenzenesulfonic Acid	31-35	interferon gamma	Mus musculus	164-173	
14724828-12	2003	CONCLUSIONS: Extended TNBS treatment of mice yielded chronic intestinal inflammation-associated fibrosis with extensive fibrogenic ECM changes that could be counteracted by specific blockade of NF-kappa B.	Trinitrobenzenesulfonic Acid	22-26	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	194-204